1. Home
  2. QXO vs PEN Comparison

QXO vs PEN Comparison

Compare QXO & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QXO Inc.

QXO

QXO Inc.

HOLD

Current Price

$16.92

Market Cap

12.6B

Sector

Technology

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$316.62

Market Cap

12.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QXO
PEN
Founded
1988
2004
Country
United States
United States
Employees
7794
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
12.8B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
QXO
PEN
Price
$16.92
$316.62
Analyst Decision
Strong Buy
Hold
Analyst Count
14
16
Target Price
$32.85
$360.14
AVG Volume (30 Days)
16.1M
363.1K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1155.56
EPS
N/A
0.82
Revenue
N/A
$1,403,665,000.00
Revenue This Year
$70.27
$14.34
Revenue Next Year
$38.75
$13.71
P/E Ratio
N/A
$387.35
Revenue Growth
N/A
17.50
52 Week Low
$14.75
$221.26
52 Week High
$27.61
$362.41

Technical Indicators

Market Signals
Indicator
QXO
PEN
Relative Strength Index (RSI) 48.40 36.97
Support Level $15.43 $302.19
Resistance Level $17.96 $322.24
Average True Range (ATR) 0.97 2.44
MACD 0.17 -0.00
Stochastic Oscillator 63.85 19.83

Price Performance

Historical Comparison
QXO
PEN

About QXO QXO Inc.

QXO Inc is a publicly traded distributor of building products in North America. The company is executing its plan to become the tech-enabled leader in the around $800 billion building products distribution industry and generate outsized value for its shareholders. The group expects to achieve its target of nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.

About PEN Penumbra Inc.

Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.

Share on Social Networks: